COVID-19
During COVID-19 pandemic, health systems face an unprecedented number of patients requiring urgent care. Individual containment and self-managing mild symptoms will help to relieve pressure on health systems. The self-care industry is focused on and commited to safeguarding the stock continuity of necessary products to all European citizens during this pandemic.
In close collaboration with the European Commission, the European Medicines Agency and other European and national competent authorities, AESGP is coordinating efforts to inform, predict and resolve problems to ensure uninterrupted supply of self-care products.
News digest on COVID-19
COVID-19
Self-care
Shortages
Statement
AESGP remarks on EU4Health Programme
COVID-19
AESGP Responds to EPF's Open Memo to the Health Industry
COVID-19
European Industry trade and supply chain needs to respond to Covid-19
COVID-19
Statement
EU Health Coalition calls for more solidarity and coordinated EU action to tackle COVID-19
COVID-19
Medical Devices
OTC
Self-care
AESGP and the COVID-19 pandemic
COVID-19
Covid-19: AESGP continuity planning
COVID-19
OTC
Press release
Self-care
WHO confirms no scientific evidence linking ibuprofen and the worsening of COVID-19
COVID-19
EMA
OTC
Press release
Self-care
No link between the use of ibuprofen and worsening of COVID-19
COVID-19
Self-care